Figure_3.tif (546.48 kB)
Combined FGFR3 and TP53 mutation frequencies according to the stage/grade group.
figure
posted on 2012-12-13, 01:42 authored by Yann Neuzillet, Xavier Paoletti, Slah Ouerhani, Pierre Mongiat-Artus, Hany Soliman, Hugues de The, Mathilde Sibony, Yves Denoux, Vincent Molinie, Aurélie Herault, May-Linda Lepage, Pascale Maille, Audrey Renou, Dimitri Vordos, Claude-Clément Abbou, Ashraf Bakkar, Bernard Asselain, Nadia Kourda, Amel El Gaaied, Karen Leroy, Agnès Laplanche, Simone Benhamou, Thierry Lebret, Yves Allory, François RadvanyiProportion of tumours with both FGFR3 and TP53 mutations (orange), with FGFR3 mutations and wild-type TP53 wild-type (grey), with wild-type FGFR3 and mutated TP53 (purple), or with wild-type FGFR3 and wild-type TP53 (blue), as a function of stage/grade. The number of cases in each subgroup is indicated in the corresponding rectangle.
